Citations

Mayo Clinic

Showing 10 of 108599 citations.

Shear wave phase velocity dispersion estimation in viscoelastic materials using the Multiple Signal Classification method
Qiang, Bo, Amador, Carolina , Urban, Matthew W. , Kijanka, Piotr , Song, Pengfei , Chen, Shigao

The Journal of the Acoustical Society of America | June 10, 2017 | Volume: 141 | Issue: 5_Supplement | Pages: 3720-3720

10.1121/1.4988145 Get It

Shear wave elastography (SWE) is clinically used for the measurement of soft tissue mechanical properties. Most SWE methods assume that the tissue is elastic, but soft tissues are inherently viscoelastic. The viscoelasticity can be characterized by examining phase velocity dispersion. Methods to extract the phase velocities from the spatiotemporal data, v(x,t), involve using a two-dimensional Fourier transform. The Fourier representation, V(k,f), is searched for peaks that correspond to the phase velocities. We present a method that uses the Multiple Signal Classification (MUSIC) method to provide robust estimation of the phase velocity dispersion curves. We compared results from the MUSIC method with the current approach of searching for peaks in the V(k,f) representation. We tested this method on digital phantom data created using finite element models (FEMs) in viscoelastic media excited by a simulated acoustic radiation force push from a curved linear array. We evaluated the algorithm with different levels of added noise. Additionally, we tested the methods on data acquired in viscoelastic phantoms with a Verasonics system. The MUSIC algorithm provided dispersion estimation with lower errors than the conventional peak search strategy. This method can be used for evaluation of wave velocity dispersion in viscoelastic tissues and guided wave propagation. [This work was supported in part by grant R01DK092255.]
An ultrasound surface wave elastography technique for noninvasive measurement of surface lung tissue
Osborn, Thomas G. , Greenleaf, James F. , Kalra, Sanjay , Zhang, Xiaoming , Zhou, Boran , Bartholmai, Brian J.

The Journal of the Acoustical Society of America | June 10, 2017 | Volume: 141 | Issue: 5_Supplement | Pages: 3721-3721

10.1121/1.4988149 Get It

Ultrasonography is not widely used in clinic for lung assessment because ultrasound cannot image deep lung tissue. In this abstract, we present a novel technique, lung ultrasound surface wave elastography (LUSWE), for measuring the elastic properties of superficial lung tissue. In LUSWE, a small, local, and 0.1 second harmonic vibration is generated on the chest of a subject. The speed of surface wave on the lung is measured by using an ultrasound probe. We are evaluating LUSWE for assessing patients with interstitial lung disease (ILD). LUSWE may be useful for assessing ILD because most ILD patients have typical fibrotic scars in the peripheral and subpleural regions of the lung. In a large clinical study of ILD patients, we measure both lungs through six intercostal spaces for patients and controls. The surface wave speed is measured at 100 Hz, 150 Hz, and 200 Hz. In an example, the surface wave speed is 1.88 ± 0.11 m/s and 3.3 ± 0.37 m/s, respectively, for a healthy subject and an ILD patient at 100 Hz and in the same intercostal space. LUSWE may compliment the clinical standard high-resolution computed tomography for assessing ILD. LUSWE may be useful for assessing other lung disorders.
Role of diastolic function indices in the risk stratification of patients with mixed aortic valve disease
Egbe, Alexander C. , Khan, Arooj R., Boler, Amber, Said, Sameh M. , Geske, Jeffrey B. , Miranda, William R. , Akintoye, Emmanuel , Connolly, Heidi M. , Warnes, Carole A. , Oh, Jae K. , Geske, Jeffrey B

European Heart Journal - Cardiovascular Imaging | June 10, 2017 | Volume: 19 | Issue: 6 | Pages: 668-674

10.1093/ehjci/jex148 | PMID 28655164 Get It

Cerebrovascular disease affects brain structural integrity long before clinically overt strokes
Hooshmand, Babak , Knopman, David S.

Neurology | June 10, 2017 | Volume: 89 | Issue: 2 | Pages: 110-111

10.1212/wnl.0000000000004098 | PMID 28600461 Get It

Adverse Events Detection Through Global Trigger Tool Methodology: Results From a 5-Year Study in an Italian Hospital and Opportunities to Improve Interrater Reliability
Mortaro, Alberto, Moretti, Francesca , Pascu, Diana Sorina, Tessari, Lorella, Pancheri, Serena, Garon, Marta, Mazzi, Mariangela, Montresor, Paolo, Naessens, James M. , Tessari, Lorella, Tardivo, Stefano , Romano, Gabriele , Montresor, Paolo

Journal of Patient Safety | June 9, 2017 | Volume: 17 | Issue: 6 | Pages: 451-457

10.1097/pts.0000000000000381 | PMID 28598897 Get It

Objective Global Trigger Tool (GTT) has been proposed as a low-cost method to detect adverse events (AEs). The validity of the methodology has been questioned because of moderate interrater agreement. Continuous training has been suggested as a means to improve consistency over time. We present the main findings of the implementation of the Italian version of the GTT and evaluate efforts to improve the interrater reliability over time. Methods The Italian version of the GTT was developed and implemented at the San Bonifacio Hospital, a 270-bed secondary care acute hospital in Verona, Italy. Ten clinical records randomly selected every 2 weeks were reviewed from 2009 to 2014. Two-stage interrater reliability assessment between team members was conducted on 2 subsamples of 50 clinical records before and after the implementation of specific review rules and staff training. Results Among 1320 medical records reviewed, a total of 366 AEs were found with at least 1 AE on 20.2% of all discharges, 27.7 AEs/100 admissions, and 30.6 AEs/1000 patient-days. Adverse events with harm score E and F were respectively 58.2% (n = 213) and 38.8% (n = 142). First round interrater reliability was comparable with other international studies. The interrater agreement improved significantly after intervention (κ interrater I = 0.52, κ interrater II = 0.80, P < 0.001). Conclusions Despite the improvements in the interrater consistency, overall results did not show any significant trend in AEs over time. Future studies may be directed to apply and adapt the GTT methodology to more specific settings to explore how to improve its sensitivity.
Diagnosing Large Vestibular Aqueduct: Radiological Review of High-Resolution CT Versus High-Resolution Volumetric MRI
Deep, Nicholas L. , Carlson, Matthew L. , Weindling, Steven M. , Barrs, David M., Driscoll, Colin L. W., Lohse, Christine M. , Lane, John I. , Hoxworth, Joseph M.

Otology & Neurotology | June 9, 2017 | Volume: 38 | Issue: 7 | Pages: 948-955

10.1097/mao.0000000000001482 | PMID 28604576 Get It

Objectives: To compare the diagnostic yield of high-resolution volumetric T2-weighted MRI (HRT2-MRI) with high-resolution computed tomography (HRCT) for diagnosis of large vestibular aqueduct (LVA). Study Design: Three board-certified neuroradiologists performed an independent, blinded radiological review for diagnosing LVA with 2:1 age-matched controls on patients with both HRCT and HRT2-MRI imaging. Setting: Tertiary referral center. Patients: All patients between 2002 and 2016 with hearing loss who underwent both HRCT and HRT2-MRI and were diagnosed with LVA on either modality. Main Outcome Measures: Concordance rate for LVA between HRCT and HRT2-MRI. Results: Concordance rate for HRCT and HRT2-MRI for diagnosing LVA was 88% (124/141) when assessing both the midpoint and external aperture diameters. Fifteen ears had LVA on computed tomography (CT), but not on magnetic resonance imaging (MRI); in comparison, two ears had LVA on MRI, but not on CT (p = 0.002). Excellent inter-rater reliability among the three radiologists was demonstrated. Conclusion: Historically, HRCT has been the imaging modality of choice for diagnosing LVA. Although a higher concordance rate of HRT2-MRI was found compared with previous studies utilizing earlier MRI technology, HRCT still detected a larger number of patients with clinically significant hearing loss compared with MRI. Given the high concordance rate and efficacy of both modalities in diagnosing LVA, the ultimate decision of which modality to choose may depend on other patient-specific and clinical factors.
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial
Pollack, Charles V. , Davoudi, Farideh, Diercks, Deborah B. , Lim, Soo Teik , Schulte, Phillip J. , Špinar, Jindřich , Steg, Philippe Gabríel , Storey, Robert F. , Himmelmänn, Anders, Wallentin, Lars , Cannon, Christopher P. , Investigators, on behalf of the PLATO, Becker, Richard C. , James, Stefan Karl , Investigators, on behalf of the PLATO, Storey, Robert F , Steg, P Gabriel

Clinical Cardiology | June 9, 2017 | Volume: 40 | Issue: 6 | Pages: 390-398

10.1002/clc.22733 | PMID 28598510 Get It

AbstractBackgroundGuidelines suggest that “upstream” P2Y12 receptor antagonists should be considered in patients with non–ST‐segment elevation acute coronary syndromes (NSTE‐ACS).HypothesisEarly use of ticagrelor in patients managed with an invasive strategy would be more effective than clopidogrel because of its more rapid onset of action and greater potency.MethodsIn the PLATO trial, 6792 NSTE‐ACS patients were randomized to ticagrelor or clopidogrel (started prior to angiography) and underwent angiography within 72 hours of randomization. We compared efficacy and safety outcomes of ticagrelor vs clopidogrel as a function of “early” (<3h) vs “late” (≥3h) time to angiography. Adjusted Cox proportional hazards models evaluated interaction between randomized treatment and time from randomization to angiography on subsequent outcomes.ResultsOverall, a benefit of ticagrelor vs clopidogrel for cardiovascular death/myocardial infarction/stroke was seen at day 7 (hazard ratio [HR]: 0.67, P = 0.002), day 30 (HR: 0.81, P = 0.042), and 1 year (HR: 0.80, P = 0.0045). There were no significant interactions in the <3h vs ≥3h groups at any timepoint. For major bleeding, overall there was no significant increase (HR: 1.04, 95% confidence interval: 0.85‐1.27); but there was a significant interaction with no difference between ticagrelor and clopidogrel in the early group (HR: 0.79), but higher bleeding risk with ticagrelor in the late angiography group, at 7 days (HR: 1.51, Pint = 0.002). Patterns were similar at 30 days and 1 year.ConclusionsThe benefit of ticagrelor over clopidogrel was consistent in those undergoing early and late angiography, supporting upstream use of ticagrelor.
Effects of primary and recurrent sacral chordoma on the motor and nociceptive function of hindlimbs in rats: an orthotopic spine model
Sarabia-Estrada, Rachel , Ruiz‐Valls, Alejandro , Shah, Sagar , Ahmed, Abdul-Kareem , Ordoñez, Alvaro A. , Guerrero‐Cazares, Hugo , Jiménez‐Estrada, Ismael , Velarde, Esteban, Phillips, Neil A., Petteys, Rory J. , Jain, Sanjay K. , Gallia, Gary L. , Gokaslan, Ziya L., Quiñones‐Hinojosa, Alfredo , Sciubba, Daniel M. , Shah, Sagar R, Guerrero-Cázares, Hugo, Rodríguez, Fausto J. , Tyler, Betty , Li, Yuxin , Goodwin, C. Rory , Guerrero-Cazares, Hugo , Sarabia-Estrada, Rachel

Journal of Neurosurgery: Spine | June 9, 2017 | Volume: 27 | Issue: 2 | Pages: 215-226

10.3171/2016.12.spine16917 | PMID 28598292 Get It

OBJECTIVEChordoma is a slow-growing, locally aggressive cancer that is minimally responsive to conventional chemotherapy and radiotherapy and has high local recurrence rates after resection. Currently, there are no rodent models of spinal chordoma. In the present study, the authors sought to develop and characterize an orthotopic model of human chordoma in an immunocompromised rat.METHODSThirty-four immunocompromised rats were randomly allocated to 4 study groups; 22 of the 34 rats were engrafted in the lumbar spine with human chordoma. The groups were as follows: UCH1 tumor–engrafted (n = 11), JHC7 tumor–engrafted (n = 11), sham surgery (n = 6), and intact control (n = 6) rats. Neurological impairment of rats due to tumor growth was evaluated using open field and locomotion gait analysis; pain response was evaluated using mechanical or thermal paw stimulation. Cone beam CT (CBCT), MRI, and nanoScan PET/CT were performed to evaluate bony changes due to tumor growth. On Day 550, rats were killed and spines were processed for H & E–based histological examination and immunohistochemistry for brachyury, S100β, and cytokeratin.RESULTSThe spine tumors displayed typical chordoma morphology, that is, physaliferous cells filled with vacuolated cytoplasm of mucoid matrix. Brachyury immunoreactivity was confirmed by immunostaining, in which samples from tumor-engrafted rats showed a strong nuclear signal. Sclerotic lesions in the vertebral body of rats in the UCH1 and JHC7 groups were observed on CBCT. Tumor growth was confirmed using contrast-enhanced MRI. In UCH1 rats, large tumors were observed growing from the vertebral body. JHC7 chordoma–engrafted rats showed smaller tumors confined to the bone periphery compared with UCH1 chordoma–engrafted rats. Locomotion analysis showed a disruption in the normal gait pattern, with an increase in the step length and duration of the gait in tumor-engrafted rats. The distance traveled and the speed of rats in the open field test was significantly reduced in the UCH1 and JHC7 tumor–engrafted rats compared with controls. Nociceptive response to a mechanical stimulus showed a significant (p < 0.001) increase in the paw withdrawal threshold (mechanical hypalgesia). In contrast, the paw withdrawal response to a thermal stimulus decreased significantly (p < 0.05) in tumor-engrafted rats.CONCLUSIONSThe authors developed an orthotopic human chordoma model in rats. Rats were followed for 550 days using imaging techniques, including MRI, CBCT, and nanoScan PET/CT, to evaluate lesion progression and bony integrity. Nociceptive evaluations and locomotion analysis were performed during follow-up. This model reproduces cardinal signs, such as locomotor and sensory deficits, similar to those observed clinically in human patients. To the authors’ knowledge, this is the first spine rodent model of human chordoma. Its use and further study will be essential for pathophysiology research and the development of new therapeutic strategies.
Conventional and high-resolution vessel wall MRI of intracranial aneurysms: current concepts and new horizons
Brinjikji, Waleed , Mossa‐Basha, Mahmud , Kallmes, David F. , Huston, John , Lehman, Vance T. , Lanzino, Giuseppe , Rabinstein, Alejandro A. , Mossa-Basha, Mahmud

Journal of Neurosurgery | June 9, 2017 | Volume: 128 | Issue: 4 | Pages: 969-981

10.3171/2016.12.jns162262 | PMID 28598273 Get It

Intracranial aneurysms are heterogeneous in histopathology and imaging appearance. The biological behavior of different types of aneurysms is now known to depend on the structure and physiology of the aneurysm wall itself in addition to intraluminal flow and other luminal features. Aneurysm wall structure and imaging markers of physiology such as aneurysm wall enhancement have been assessed in many prior investigations using conventional-resolution MRI. Recently, high-resolution vessel wall imaging (HR-VWI) techniques with MRI have been introduced. Reports of findings on high-resolution imaging have already emerged for many types of aneurysms demonstrating detailed characterization of wall enhancement, thickness, and components, but many questions remain unexplored. This review discusses the key HR-VWI literature to date. Aneurysm wall findings on conventional-resolution MRI are also discussed as these may help one understand the potential utility and findings on HR-VWI for various aneurysm types. The authors have illustrated these points with several examples demonstrating both features already described in the literature and novel cases demonstrating the potential for future clinical and research applications.
Falls From the O.R. or Procedure Table
Prielipp, Richard C., Weinkauf, Julia L., Esser, Thomas M., Warner, Mark A. , Thomas, Brian J

Anesthesia & Analgesia | June 9, 2017 | Volume: 125 | Issue: 3 | Pages: 846-851

10.1213/ane.0000000000002125 | PMID 28598918 Get It

Patient safety secured by constant vigilance remains a primary responsibility of every anesthesia professional. Although significant attention has been focused on patient falls occurring before and after surgery, a potentially catastrophic complication is when patients fall off an operating room or procedure table during anesthesia care. Because such events are (fortunately) uncommon, and because very little information is published in our literature, we queried 2 independent closed claims databases (the American Society of Anesthesiologists Closed Claims Project and the secure records of a private, anesthesia specialty-specific liability insurer) for information. We acquired documentation of patient events where a fall occurred during anesthesia care, noting the surrounding conditions of the provider, the patient, and the environment at the time of the event. We identified 21 claims (1.2% of cases) from the American Society of Anesthesiologists Closed Claims Project, while information from a private liability insurer identified falls in only 0.07% of cases. The percentage of these patients under general, regional, or monitored anesthesia care anesthesia was 71.5%, 19.5%, and 9.5%, respectively. To educate personnel about these uncommon events, we summarized this cohort with illustrative examples in a series of mini-case reports, noting that both inpatients and outpatients undergoing a broad array of procedures with various anesthetic techniques within and outside operating rooms may be vulnerable to patient falls. Based on detailed reports, we created 2 supplementary videos to further illuminate some of the unique mechanisms by which these events and their resulting injuries occur. When such information was available, we also noted the associated liability costs of defending and settling malpractice claims associated with these events. Our goal is to inform anesthesia and perioperative personnel about the common patient, provider, and environmental risk factors that appear to contribute to these mishaps, and suggest key strategies to mitigate the risks.